177 related articles for article (PubMed ID: 25961922)
1. p38γ MAPK is required for inflammation-associated colon tumorigenesis.
Yin N; Qi X; Tsai S; Lu Y; Basir Z; Oshima K; Thomas JP; Myers CR; Stoner G; Chen G
Oncogene; 2016 Feb; 35(8):1039-48. PubMed ID: 25961922
[TBL] [Abstract][Full Text] [Related]
2. Pro-oncogenic role of alternative p38 mitogen-activated protein kinases p38γ and p38δ, linking inflammation and cancer in colitis-associated colon cancer.
Del Reino P; Alsina-Beauchamp D; Escós A; Cerezo-Guisado MI; Risco A; Aparicio N; Zur R; Fernandez-Estévez M; Collantes E; Montans J; Cuenda A
Cancer Res; 2014 Nov; 74(21):6150-60. PubMed ID: 25217523
[TBL] [Abstract][Full Text] [Related]
3. p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
Qi X; Yin N; Ma S; Lepp A; Tang J; Jing W; Johnson B; Dwinell MB; Chitambar CR; Chen G
Stem Cells; 2015 Sep; 33(9):2738-47. PubMed ID: 26077647
[TBL] [Abstract][Full Text] [Related]
4. Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.
Zur R; Garcia-Ibanez L; Nunez-Buiza A; Aparicio N; Liappas G; Escós A; Risco A; Page A; Saiz-Ladera C; Alsina-Beauchamp D; Montans J; Paramio JM; Cuenda A
Oncotarget; 2015 May; 6(15):12920-35. PubMed ID: 26079427
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of IRE1α inhibits colonic tumorigenesis through decreasing β-catenin and IRE1α targeting suppresses colon cancer cells.
Li XX; Zhang HS; Xu YM; Zhang RJ; Chen Y; Fan L; Qin YQ; Liu Y; Li M; Fang J
Oncogene; 2017 Nov; 36(48):6738-6746. PubMed ID: 28825721
[TBL] [Abstract][Full Text] [Related]
6. p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.
Meng F; Zhang H; Liu G; Kreike B; Chen W; Sethi S; Miller FR; Wu G
Neoplasia; 2011 May; 13(5):472-82. PubMed ID: 21532888
[TBL] [Abstract][Full Text] [Related]
7. p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion.
Qi X; Tang J; Loesch M; Pohl N; Alkan S; Chen G
Cancer Res; 2006 Aug; 66(15):7540-7. PubMed ID: 16885352
[TBL] [Abstract][Full Text] [Related]
8. p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Wang F; Qi XM; Wertz R; Mortensen M; Hagen C; Evans J; Sheinin Y; James M; Liu P; Tsai S; Thomas J; Mackinnon A; Dwinell M; Myers CR; Bartrons Bach R; Fu L; Chen G
Cancer Res; 2020 Aug; 80(16):3251-3264. PubMed ID: 32580961
[TBL] [Abstract][Full Text] [Related]
9. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction.
Hou SW; Zhi HY; Pohl N; Loesch M; Qi XM; Li RS; Basir Z; Chen G
Cancer Res; 2010 Apr; 70(7):2901-10. PubMed ID: 20332238
[TBL] [Abstract][Full Text] [Related]
10. Alternative p38 MAPKs are essential for collagen-induced arthritis.
Criado G; Risco A; Alsina-Beauchamp D; Pérez-Lorenzo MJ; Escós A; Cuenda A
Arthritis Rheumatol; 2014 May; 66(5):1208-17. PubMed ID: 24782184
[TBL] [Abstract][Full Text] [Related]
11. p38γ is essential for cell cycle progression and liver tumorigenesis.
Tomás-Loba A; Manieri E; González-Terán B; Mora A; Leiva-Vega L; Santamans AM; Romero-Becerra R; Rodríguez E; Pintor-Chocano A; Feixas F; López JA; Caballero B; Trakala M; Blanco Ó; Torres JL; Hernández-Cosido L; Montalvo-Romeral V; Matesanz N; Roche-Molina M; Bernal JA; Mischo H; León M; Caballero A; Miranda-Saavedra D; Ruiz-Cabello J; Nevzorova YA; Cubero FJ; Bravo J; Vázquez J; Malumbres M; Marcos M; Osuna S; Sabio G
Nature; 2019 Apr; 568(7753):557-560. PubMed ID: 30971822
[TBL] [Abstract][Full Text] [Related]
12. Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma.
Zhang XH; Nam S; Wu J; Chen CH; Liu X; Li H; McKeithan T; Gong Q; Chan WC; Yin HH; Yuan YC; Pillai R; Querfeld C; Horne D; Chen Y; Rosen ST
J Invest Dermatol; 2018 Nov; 138(11):2377-2387. PubMed ID: 29758280
[TBL] [Abstract][Full Text] [Related]
13. p38γ and p38δ Are Involved in T Lymphocyte Development.
Risco A; Martin-Serrano MA; Barber DF; Cuenda A
Front Immunol; 2018; 9():65. PubMed ID: 29434594
[TBL] [Abstract][Full Text] [Related]
14. The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating
Yin N; Lepp A; Ji Y; Mortensen M; Hou S; Qi XM; Myers CR; Chen G
J Biol Chem; 2017 Sep; 292(36):15070-15079. PubMed ID: 28739874
[TBL] [Abstract][Full Text] [Related]
15. Targeting p38γ to inhibit human colorectal cancer cell progression.
Su C; Sun Q; Liu S; Wang H; Feng L; Cao Y
Biochem Biophys Res Commun; 2019 Sep; 517(1):172-179. PubMed ID: 31349971
[TBL] [Abstract][Full Text] [Related]
16. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
[TBL] [Abstract][Full Text] [Related]
17. Essential role for p38alpha MAPK but not p38gamma MAPK in Igf2 expression and myoblast differentiation.
Lovett FA; Cosgrove RA; Gonzalez I; Pell JM
Endocrinology; 2010 Sep; 151(9):4368-80. PubMed ID: 20610565
[TBL] [Abstract][Full Text] [Related]
18. p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease.
Qi XM; Chen G
Cells; 2023 Jun; 12(13):. PubMed ID: 37443708
[TBL] [Abstract][Full Text] [Related]
19. p38γ Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response.
Hou S; Suresh PS; Qi X; Lepp A; Mirza SP; Chen G
J Biol Chem; 2012 Aug; 287(33):27895-905. PubMed ID: 22730326
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.
Gupta J; Igea A; Papaioannou M; Lopez-Casas PP; Llonch E; Hidalgo M; Gorgoulis VG; Nebreda AR
Oncotarget; 2015 Apr; 6(11):8539-51. PubMed ID: 25890501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
